Ethno-pharmacological Study about Lafoensia replicata Pohl. in East Maranhão, Brazil: A Promising Species for Bioprospection
DOI:
https://doi.org/10.5380/dma.v39i0.46681Keywords:
mangabeira, traditional medicine, ethno-botanyAbstract
This work aimed at carrying out a study on the local therapeutic uses of mangabeira (Lafoensia replicata Pohl.), an important plant in the northeastern cerrado. 32 interviews were conducted with informants from the community Manga, Barão do Grajaú, Maranhão. Respondents, 18 women and 14 men, reported eight different uses for the plant. Regarding the number of instructions for use, there were no significant differences between genders, eight nominations described by women and seven by men. Regarding the distinctions of knowledge among the age group proposed for the analysis, there were no statistical differences. The plant part most indicated for use was the stem bark. All informants indicated consensually that the medicine prepared from the plant should be administered orally and over half of the respondents mentioned that the plant had no restrictions on consumption (53%). However, 17 respondents said that the treatment is contraindicated during pregnancy, and even five people did not recommend the use on children. It was not possible to substantiate the ethno-pharmacological information in this study with the literature since there is insufficient research on this species. There is some research focusing on uses and activities of Lafoensia pacari A. St.-Hil, therefore, this study also recommends L. replicata Pohl. as a potential therapeutic species.
Downloads
Published
How to Cite
Issue
Section
License
Copyright on works published in this journal rests with the author, with first publication rights for the journal. The content of published works is the sole responsibility of the authors. DMA is an open access journal and has adopted the Creative Commons Attribution 4.0 Not Adapted (CC-BY) license since January 2023. Therefore, when published by this journal, articles are free to share (copy and redistribute the material in any medium or format for any purpose, even commercial) and adapt (remix, transform, and create from the material for any purpose, even commercial). You must give appropriate credit, provide a link to the license and indicate if changes have been made.
The contents published by DMA from v. 53, 2020 to v. 60, 2022 are protected by the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license.
DMA has been an open access journal since its creation, however, from v.1 of 2000 to v. 52 of 2019, the journal did not adopt a Creative Commons license and therefore the type of license is not indicated on the first page of the articles.







.png)




